XPO's strong fundamentals and market strategy make it a hold despite high valuations and risks. Read an investment analysis ...
Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...
Q4 2024 Earnings Call Transcript February 13, 2025 Republic Services, Inc. beats earnings expectations. Reported EPS is $1.58 ...